It has been reported that FOXA2 is highly expressed in colorectal cancer, participates in the epithelial–mesenchymal transition (EMT) process, and is closely related to the metastasis and clinical staging of colorectal cancer (Wang et al., 2018). Here, FOXA2 is linked to colorectal cancer.